We retrospectively assessed their associations in peripheral blood plasma samples from advanced NSCLC patients with EGFR mutations (n = 44) who received ICI-based therapy at Shanghai Chest Hospital between July 2016 and April 2021. Here, EGFR is linked to non-small cell lung carcinoma.